Impact of Response Assessment Intervals on Survival and Economic Burden in Long-Term Responders to Immunotherapy for Advanced Non-Small-Cell Lung Cancer
This study presented the first statistical evidence supporting a refined response assessment strategy for long-term responders to immunotherapy with advanced NSCLC. These findings support the adoption of a less frequent, yet equally effective, monitoring approach to make tumor surveillance more precise and cost-effective.
Authors
- Jianxin Xue (ORCID: https://orcid.org/0000-0003-4501-7538)
- Xingzhu Liu (ORCID: https://orcid.org/0000-0002-7062-5538)
- Yuxi Li (ORCID: https://orcid.org/0009-0005-1112-9656)
- Youling Gong (ORCID: https://orcid.org/0000-0001-8230-5892)
- Min Wang (ORCID: https://orcid.org/0000-0002-1288-016X)
- Vannhong Soth
Institutions
- Sichuan University (CN)
- Sichuan Cancer Hospital (CN)
Publication Details
- Journal
- Cancers
- Published
- 2025-10-14
- DOI
- https://doi.org/10.3390/cancers17203312
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Society for Medical Oncology